Current treatment status-Did not start treatment yet Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Sequential treatment for patients with chronic lymphocytic leukemia who have received bendamustine

Posted by on Sep 17, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effectiveness of obinutuzumab and venetoclax after bendamustine treatment in patients with chronic lymphocytic leukemia (CLL). This study concluded that this sequence of treatment caused no unexpected side effects. It also concluded that the outcomes were comparable to established therapies for CLL. Some...

Read More

Can ultrasound of the joints predict remission in rheumatoid arthritis?

Posted by on Sep 2, 2018 in Rheumatoid Arthritis | 0 comments

In a nutshell This study investigated if an ultrasound of the joints (musculoskeletal) can predict if remission can be achieved in patients with rheumatoid arthritis (RA). They found that ultrasound can predict if a patient with RA will achieve remission. Some background The aim of treatment for rheumatoid arthritis (RA) is to reduce disease activity....

Read More

Evaluating duvelisib for the treatment of CLL

Posted by on Aug 25, 2018 in Leukemia | 0 comments

In a nutshell This study evaluated the effectiveness and safety of duvelisib in patients with chronic lymphocytic leukemia (CLL). This study concluded that duvelisib may be an effective new therapy with manageable side effects. Some background CLL is the most common type of leukemia in adults in the U.S. Although therapy options have increased, many...

Read More

Post-surgery chemotherapy in early rectal cancer is associated with improved outcomes

Posted by on Aug 17, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the safety of localized surgery followed by chemotherapy compared with total mesorectal excision (TME; bowel and lymph nodes around the tumor are removed) in early stages (T0 to T1) of rectal cancer. Researchers suggested that local surgery followed by chemotherapy improves long term outcomes in early stages of...

Read More

New targeted therapies have potential to improve overall survival for patients with EGFR-mutation positive NSCLC

Posted by on Aug 8, 2018 in Lung cancer | 0 comments

In a nutshell This study compared dacomitinib (PF-00299804) to gefitinib (Iressa) as a first treatment for patients with EGFR-mutation positive non-small-cell lung cancer. The authors concluded that treatment with dacomitinib provided an improved overall survival compared to gefitinib. Some background Current cancer therapy heavily...

Read More

Using focal lesions seen on PET-CT to monitor outcome in multiple myeloma

Posted by on Jul 18, 2018 in Multiple Myeloma | 0 comments

In a nutshell This study examined the use of PET-CT imaging to monitor response to treatment for multiple myeloma. The study concluded that treatment to suppress focal lesions seen on PET-CT is an important goal for newly diagnosed patients. Some background One way to improve outcomes in multiple myeloma is to customize treatment based on the...

Read More